IP Library › Assignment 061648/0491
Patent Assignment
Reel/Frame 061648/0491

Assignment of Assignor's Interest

Recorded: 2022-11-03 Pages: 16
Assignor
BIOXCEL THERAPEUTICS, INC.
Executed: 2022-11-02
Assignee
ONKOSXCEL THERAPEUTICS, LLC
555 LONG WHARF DRIVE, 12TH FLOOR, NEW HAVEN, CONNECTICUT, 06511
Covered Properties (31)
A Novel Approach for Treatment of Cancer Using Immunomodulation
Predictive and Diagnostic Methods for Prostate Cancer
Methods and Compositions for Treating Cancer by Modifying Multiple Arms of the Immune System
Combination Therapies for Treating Disease Using an Innate Immunity Modifier and an OX40 Agonist
Novel Approach for Treatment of Cancer Using Immunomodulation
Treatment Regimen for Cancer Using Immunomodulation
Approach for Treatment of Cancer via Immunomodulation by Using Talabostat
Application: 15/467,781 →
Publication: US 2017/0266280
Treatment of Sarcoma Using Immunomodulation
Application: 17/674,371 →
Publication: US 2022/0257759
Novel approach for treatment of cancer using immunomodulation
Application: 62/193,348 →
Novel approach for treatment of cancer using immunomodulation
Application: 62/204,495 →
Predictive and Diagnostic Methods for Prostate Cancer
Application: 62/443,831 →
Predictive and Diagnostic Methods for Cancer
Application: 62/473,507 →
Predictive and Diagnostic Methods for Cancer
Application: 62/561,218 →
Methods and Compositions for Treating Cancer by Modifying Multiple Arms of the Immune System
Application: 62/584,999 →
Methods and Compositions for Treating Cancer by Modifying Multiple Arms of the Immune System
Application: 62/629,473 →
Methods and Compositions for Treating Cancer by Modifying Multiple Arms of the Immune System
Application: 62/679,576 →
Methods and Compositions for Treating Cancer by Modifying Multiple Arms of the Immune System
Application: 62/712,457 →
Combination Therapies for Treating Disease Using an Innate Immunity Modifier and an Immune Checkpoint Inhibitor, and an OX40 Agonist
Application: 62/777,350 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 62/777,352 →
Combination Therapies for Treating Disease Using an Innate Immunity Modifier and an OX40 Agonist
Application: 62/790,569 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 62/924,429 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 62/971,548 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/029,066 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/069,405 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/088,038 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/092,039 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/105,679 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/107,053 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/139,594 →
Novel Approach for Treatment of Cancer Using Immunomodulation
Application: 63/150,493 →
Stable Tablet Formulations of Talabostat
Application: 63/317,726 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 3, 2016
From: RASTELLI, LUCA; SAPRA, APARNA K.; MEHTA, VIMAL D.
To: BIOXCEL CORPORATION
Reel/Frame 039334/0168 →
Assignment of Assignor's Interest May 18, 2017
From: RASTELLI, LUCA; SAPRA, APARNA KATOCH; MEHTA, VIMAL
To: BIOXCEL CORPORATION
Reel/Frame 042493/0776 →
Assignment of Assignor's Interest Jul 7, 2017
From: RASTELLI, LUCA; NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 043115/0772 →
Assignment of Assignor's Interest Nov 8, 2017
From: RASTELLI, LUCA; NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 044760/0889 →
Assignment of Assignor's Interest Nov 9, 2017
From: RASTELLI, LUCA; NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 044079/0875 →
Assignment of Assignor's Interest Nov 17, 2017
From: BIOXCEL CORPORATION
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 044482/0489 →
Assignment of Assignor's Interest Nov 8, 2018
From: ZALEVSKY, JONATHAN; CHARYCH, DEBORAH H.
To: NEKTAR THERAPEUTICS
Reel/Frame 047447/0862 →
Assignment of Assignor's Interest Nov 13, 2018
From: BIOXCEL CORPORATION
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 047482/0464 →
Assignment of Assignor's Interest Nov 13, 2018
From: MACDOUGALL, JOHN
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 047482/0479 →
Assignment of Assignor's Interest Nov 13, 2018
From: MEHTA, VIMAL D.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 047482/0382 →
Assignment of Assignor's Interest Nov 13, 2018
From: NANDABALAN, KRISHNAN; RASTELLI, LUCA
To: BIOXCEL CORPORATION
Reel/Frame 047482/0440 →
Assignment of Assignor's Interest Apr 4, 2019
From: O'NEILL, VINCENT JOHN
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 048796/0402 →
Assignment of Assignor's Interest Jul 27, 2020
From: O'NEILL, VINCENT J.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053313/0735 →
Assignment of Assignor's Interest Aug 10, 2020
From: GUPTA, SNIGDHA
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 053447/0100 →
Assignment of Assignor's Interest Aug 10, 2020
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053447/0118 →
Assignment of Assignor's Interest Aug 10, 2020
From: MEHTA, VIMAL D.; RASTELLI, LUCA; MACDOUGALL, JOHN
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053446/0687 →
Assignment of Assignor's Interest Nov 8, 2021
From: O'NEILL, VINCENT J.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 058043/0459 →
Assignment of Assignor's Interest Mar 10, 2022
From: O'NEILL, VINCENT J.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 059221/0868 →
Assignment of Assignor's Interest Mar 23, 2022
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 059377/0616 →
Assignment of Assignor's Interest Mar 23, 2022
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 059377/0584 →
Assignment of Assignor's Interest Oct 28, 2022
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 061582/0096 →
Assignment of Assignor's Interest Oct 28, 2022
From: NEUHEIT PHARMA TECHNOLOGIES PVT LTD.
To: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 061582/0069 →
Assignment of Assignor's Interest Oct 28, 2022
From: VENKATESWARLU, VOBALABOINA; NAGABANDI, VIJAYKUMAR
To: NEUHEIT PHARMA TECHNOLOGIES PVT LTD.
Reel/Frame 061582/0012 →
Assignment of Assignor's Interest May 12, 2023
From: O'NEILL, VINCENT J.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 063628/0553 →
Security Interest Sep 11, 2024
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068938/0906 →